Pacer Advisors’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,984
Closed -$24.4K 3783
2024
Q1
$24.4K Buy
+2,984
New +$24.5K ﹤0.01% 3405
2021
Q2
Sell
-2,288
Closed -$70K 1531
2021
Q1
$70K Sell
2,288
-116
-5% -$4.34K ﹤0.01% 1371
2020
Q4
$92K Buy
+2,404
New +$100K ﹤0.01% 1375

Other funds holding REPL

Pacer Advisors's REPL Position: Q2 2024 in Review

Pacer Advisors sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 2,984 shares — an estimated $24.4K sold.

Pacer Advisors first reported a position in REPL in Q4 2020 and held it in 3 quarters. The position peaked at $92K in Q4 2020. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Pacer Advisors reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Pacer Advisors sold 2,984 Replimune Group shares in Q2 2024, an estimated $24.4K.
  • Pacer Advisors first reported a position in Replimune Group in Q4 2020 and held it in 3 quarters.
  • Pacer Advisors's Replimune Group position peaked at $92K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.